Vera Therapeutics, Inc. Operating Lease, Payments in USD from 2021 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Vera Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2021 to Q1 2025.
  • Vera Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2025 was $634K, a 17% decline year-over-year.
  • Vera Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $3.12M, a 3.87% increase from 2023.
  • Vera Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $3M, a 9.73% increase from 2022.
  • Vera Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $2.73M.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)

Vera Therapeutics, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $634K -$130K -17% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q1 2024 $764K +$18K +2.41% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q1 2023 $746K +$90K +13.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $656K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11

Vera Therapeutics, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3.12M +$116K +3.87% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 $3M +$266K +9.73% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 $2.73M +$2.73M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.